Casdin Capital
About Casdin Capital
Casdin Capital is a fundamental research investment firm focused on the life sciences and healthcare industry.
Investment focus
Stages
Sectors
Portfolio (42 in our database)
KallyopeKallyope is a biotechnology company dedicated to unlocking the therapeutic potential of the gut-brain axis.Series D · $479M raisedHelixHelix is a population genomics company that is working to advance genomics research and integrate genomic data into clinical care.Series C · $403M raisedGenomaticaGenomatica manufactures sustainable chemicals from renewable feedstocks.Corporate Round · $387M raisedVividion TherapeuticsVividion is a developer of a novel drug discovery platform designed to offer transformative treatments to patients with serious illnesses.Acquired · $372M raisedSonoma BioTherapeuticsSonoma BioTherapeutics develops adoptive Treg therapies cell for autoimmune.Series B · $335M raisedGenapsysTransform the human condition by building a scalable, affordable genomic sequencing ecosystem that will support research and diagnosticsSeries D · $319M raisedPrime MedicinePrime Medicine operates as a biotechnology company that delivers the promise of gene editing using Prime Editing.Series B · $315M raisedKomodo HealthKomodo Health develops computer software that brings transparency and market intelligence to healthcare and life sciences.Series E · $314M raisedVentus TherapeuticsVentus Therapeutics develops small molecule medicines that target innate immune protein structures.Series C · $300M raisedVerana HealthVerana Health partners with leading medical associations to transform clinical data into actionable real-world evidence.Series E · $289M raisedLetsGetCheckedLetsGetChecked is an at-home health testing platform that connects customers to regulated laboratory testing.Series D · $263M raisedUmoja BiopharmaUmoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.Series B · $263M raisedMOMA TherapeuticsMOMA Therapeutics operates as a biotechnology company.Series B · $236M raisedPaigeA Global Leader in Digital DiagnosticsSeries C · $220M raisedGoldfinch BiopharmaGoldfinch is a clinical-stage biotech company focused on discovering and developing precision therapies for patients with kidney disease.Series B · $210M raisedAmunixAmunix is a biopharmaceutical company intended to discover, design, and develop novel biologics, protein, and peptide therapeutics.Acquired · $190M raisedFogPharmaFogPharma creates a new class of medicines that target human disease drivers currently considered undruggable.Series C · $184M raisedShouTiShouTi specializes in the discovery and development of drugs against a type of targets called GPCR.Series B · $174M raisedAffinia TherapeuticsAffinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.Series B · $170M raisedRemix TherapeuticsRemix Therapeutics is a biotechnology company.Series B · $151M raisedCelsius TherapeuticsCelsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.Series B · $148M raisedCedilla TherapeuticsCedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.Series B · $139M raisedImagen TechnologiesPowering the future of primary careSeries C · $135M raisedVariant BioVariant Bio is leveraging the power of human genetic diversity to discover new therapeutics.Series B · $130M raisedA2 BiotherapeuticsA2 Biotherapeutics develops novel medicines for serious illness.Series B · $129M raisedROME TherapeuticsROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.Series B · $127M raisedChroma MedicineChroma Medicine is a new genomic medicine company working on epigenetic editing.Acquired · $125M raisedGenome MedicalGenome Medical is a telegenomics technology and services company allowing access to genomic-based medicine.Series C · $121M raisedHexagon BioHexagon Bio is a data-driven biotech developing targeted small molecule therapeutics.Series B · $116M raisedVinetiVineti is a commercial cloud-based platform that expands patient access to life-saving cells and gene therapies.Series C · $115M raisedC2i GenomicsC2i Genomics provides cloud-based cancer diagnostic services to pharmaceutical and diagnostic organizations.Series B · $112M raisedDyno TherapeuticsDyno Therapeutics is a biotechnology company that uses artificial intelligence for gene therapy.Series A · $109M raisedDeepcellDeepcell uses AI to isolate and capture cells based on morphological features for multiple research and translational applications.Series B · $98M raisedInvetxInvetx is a veterinary therapeutics company that focuses on biopharmaceuticals that bring human biotechnology to animal health.Series B · $86M raisedExai BioExai Bio is a next-generation Orphan non-coding RNAs and AI based liquid biospy company.Series A · $68M raisedArzedaArzeda develops enzyme design technology to create entirely novel designer cell factories capable of industry-scale chemical production.Series B · $51M raisedXcell BiosciencesXcell Biosciences is a next-generation development and manufacturing platform for enhanced cell therapy performance.Series B · $40M raisedBeacon BiosignalsBeacon's goal is to improve human health by applying artificial intelligence to brain activity.Series A · $30M raisedCharacter BiosciencesBiopharmaceutical research and development companySeries A · $27M raisedApella TechnologyApella Technology is an AI startup that brings modern engineering to improve surgery.Series A · $24M raisedMultiply LabsMultiply Labs deploys advanced robotics technology to manufacture personalized pharmaceutical capsules.Series A · $23M raisedThyme CareThyme Care is a Nashville TN-based provider of oncology care management solutions.Series A · $22M raised